Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel Fons

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Journal De La Societe De Biologie|March 10, 2004
[Impact of mutation rate on the adaptation of gut bacteria]Antoine Giraud, Michel Fons, François Taddei
Microbiology (Reading, England)|December 31, 2005
Escherichia coli mutators: selection criteria and migration effectLudovic Le Chat, Michel Fons, Francois Taddei
World Journal of Microbiology & Biotechnology|July 19, 2012
Characterization and purification of a bacteriocin from Lactobacillus paracasei subsp. paracasei BMK2005, an intestinal isolate active against multidrug-resistant pathogensKamel Bendjeddou, Michel Fons, Pierre Strocker, et al.
Journal of Bacteriology|December 14, 2001
Trypsin mediates growth phase-dependent transcriptional tegulation of genes involved in biosynthesis of ruminococcin A, a lantibiotic produced by a Ruminococcus gnavus strain from a human intestinal microbiotaAna Gomez, Monique Ladiré, Françoise Marcille, et al.
Applied and Environmental Microbiology|July 31, 2002
Characterization of ISRgn1, a novel insertion sequence of the IS3 family isolated from a bacteriocin-negative mutant of Ruminococcus gnavus E1Ana Gomez, Monique Ladire, Francoise Marcille, et al.
Antimicrobial Agents and Chemotherapy|February 19, 2002
Mutator bacteria as a risk factor in treatment of infectious diseasesAntoine Giraud, Ivan Matic, Miroslav Radman, et al.
Research in Microbiology|November 1, 2011
Aga1, the first alpha-Galactosidase from the human bacteria Ruminococcus gnavus E1, efficiently transcribed in gut conditionsMargarita Aguilera, Harivony Rakotoarivonina, Alexandre Brutus, et al.
Frontiers in Microbiology|August 11, 2018
Heterologous Biosynthesis, Modifications and Structural Characterization of Ruminococcin-A, a Lanthipeptide From the Gut Bacterium <i>Ruminococcus gnavus</i> E1, in <i>Escherichia coli</i>Elvis L Ongey, Robert T Giessmann, Michel Fons, et al.
The Journal of Biological Chemistry|November 5, 2016
The General Stress Response σS Is Regulated by a Partner Switch in the Gram-negative Bacterium Shewanella oneidensisSophie Bouillet, Olivier Genest, Cécile Jourlin-Castelli, et al.
Plos One|November 9, 2013
Utilisation of mucin glycans by the human gut symbiont Ruminococcus gnavus is strain-dependentEmmanuelle H Crost, Louise E Tailford, Gwenaelle Le Gall, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Journal De La Societe De Biologie|March 10, 2004
[Impact of mutation rate on the adaptation of gut bacteria]Antoine Giraud, Michel Fons, François Taddei
Microbiology (Reading, England)|December 31, 2005
Escherichia coli mutators: selection criteria and migration effectLudovic Le Chat, Michel Fons, Francois Taddei
World Journal of Microbiology & Biotechnology|July 19, 2012
Characterization and purification of a bacteriocin from Lactobacillus paracasei subsp. paracasei BMK2005, an intestinal isolate active against multidrug-resistant pathogensKamel Bendjeddou, Michel Fons, Pierre Strocker, et al.
Journal of Bacteriology|December 14, 2001
Trypsin mediates growth phase-dependent transcriptional tegulation of genes involved in biosynthesis of ruminococcin A, a lantibiotic produced by a Ruminococcus gnavus strain from a human intestinal microbiotaAna Gomez, Monique Ladiré, Françoise Marcille, et al.
Applied and Environmental Microbiology|July 31, 2002
Characterization of ISRgn1, a novel insertion sequence of the IS3 family isolated from a bacteriocin-negative mutant of Ruminococcus gnavus E1Ana Gomez, Monique Ladire, Francoise Marcille, et al.
Antimicrobial Agents and Chemotherapy|February 19, 2002
Mutator bacteria as a risk factor in treatment of infectious diseasesAntoine Giraud, Ivan Matic, Miroslav Radman, et al.
Research in Microbiology|November 1, 2011
Aga1, the first alpha-Galactosidase from the human bacteria Ruminococcus gnavus E1, efficiently transcribed in gut conditionsMargarita Aguilera, Harivony Rakotoarivonina, Alexandre Brutus, et al.
Frontiers in Microbiology|August 11, 2018
Heterologous Biosynthesis, Modifications and Structural Characterization of Ruminococcin-A, a Lanthipeptide From the Gut Bacterium <i>Ruminococcus gnavus</i> E1, in <i>Escherichia coli</i>Elvis L Ongey, Robert T Giessmann, Michel Fons, et al.
The Journal of Biological Chemistry|November 5, 2016
The General Stress Response σS Is Regulated by a Partner Switch in the Gram-negative Bacterium Shewanella oneidensisSophie Bouillet, Olivier Genest, Cécile Jourlin-Castelli, et al.
Plos One|November 9, 2013
Utilisation of mucin glycans by the human gut symbiont Ruminococcus gnavus is strain-dependentEmmanuelle H Crost, Louise E Tailford, Gwenaelle Le Gall, et al.
Pageof 3